Cancer Therapy : Preclinical Anti-DLL 4 HasBroad SpectrumActivity in Pancreatic Cancer DependentonTargetingDLL 4-NotchSignaling inBothTumor and Vasculature Cells
暂无分享，去创建一个
Edward J. Kim | M. Fischer | J. Lewicki | A. Gurney | T. Hoey | D. Simeone | A. Kapoun | Xiaomei Song | Jingjiang Wu | W. Yen | L. Beviglia | V. Yeung | M. Hynes | Mark J. Hynes